netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Introduction

Preferred Prescribing list for South Staffordshire CCGs, including Burton Hospital NHS Foundation Trust and
Cannock and Stafford Hospitals Foundation Trust

Useful Links

BNFSPC  Area Prescribing Group Minutes CCG Patient Group Directions and Patient Specific Directions Prescribing Commissioning and over the counter
Policies
Feedback To Us Link
BNF For Children Formulary Working Group Minutes CCG Newsletters NHS England Patient Group Directions    High Cost Drugs
MHRA Drug Safety Updates Formulary Application Form Vaccine Update Prescribing Audits  Communications and drug discontinuations
RICaDs and ESCAs
Burton Hospital NHS Trust
Essential Shared Care Agreements
RICaDs SSSFT Mental Health Essential Shared Care Agreements
Clinical Formularies and Guidelines
Area Prescribing Group Guidelines Woundcare Formulary Antimicrobial Guidance Continence Prescribing Formulary
CCG Formularies
North Staffs Joint Formulary Birmingham and Surrounds Formulary Derbyshire Formulary  Wolverhampton Formulary

 

News Feed

01/08/2019:  Emerade® adrenaline auto-injectors supply issues

There is a short-term supply issue affecting Emerade® 500 microgram and 300 microgram adrenaline auto-injectors (AAIs). Bausch & Lomb are the sole UK supplier of Emerade® devices in the UK. New supplies of Emerade® 500 microgram are expected by the end of August 2019. Limited stock of Emerade® 300 microgram is available. Currently, new supplies are expected by the end of September 2019.

Two alternative AAI devices are available in the UK- EpiPen® and Jext®. Both Jext® and EpiPen® AAIs are currently available, however, supplies of Jext® are unlikely to be sufficient to support a significant switch to this product and therefore where there is no patient / clinician preference, EpiPen® should be considered as the first line alternative. The devices differ slightly in the administration technique and specific training is required for each device.


16/07/19: Diamorphine 5mg injection supply issue

There is currently supply issues with Diamorphine 5mg injections. The national Medicines Shortage Response Group (MSRG) have recommended the following:

Primary care, private hospitals, hospices & substance misuse treatment centres:There is sufficient diamorphine 10mg injection to support the forecasted use of the diamorphine 5mg strength. Order stock from usual wholesalers.

Secondary care NHS Trusts: Hameln's morphine 10mg injection (p/free) is the first line alternative. Trusts should order in line with historical demand. Do not stockpile which may potentiate supply issues of this product.


31.05.2019: HRT Supply Issues

There are currently stock availability issues for a number of Hormonal Replacement Therapy preperations, please establish local availability prior to issuing prescriptions. For further information and guidance please contact the Medicines Optimisation Queries Team at southstaffs.medsoptimisation@nhs.net

 


16/05/19: Epanutin 50mg Infatabs Supply Issue

Clinicians should read the attached information from the Department of Health and Social Care (DHSC) concerning global supply issues of Epanutin 50mg Infatabs until November 2019. Prescribers must exercise caution and increase patient monitoring if prescribing a product from a different manufacturer as this is a Category 1 antiepileptic drug.


11/03/2019 - Changes to the Amber drug classification on the South Staffordshire Joint Formulary as approved by Stafford & Surrounds Membership board and APG. These changes are effective from today 11th March 2019.

Amber- Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care. This replaces Amber 1 on the South Staffs Formulary.

Amb E- Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require an ESCA (Shared Care Agreement). This replaces Amber 2 on the South Staffs Formulary.

For further queries and support, please contact your Practice support pharmacist or email: southstaffs.medsoptimisation@nhs.net . Thank you.


06/11/2018 - EPS - Frequently asked questions, General Practice Guidance has been added to the Communications and Drug discontinuation tile


>>> more news

HOW TO USE

  1. The Preferred Prescribing List for the various therapeutic sections of  the British National Formulary (BNF) can be accessed via the links

   2.     PDF How to use guide

   3.   Drugs are colour coded according to the following criteria:

 

Status Description
Red Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  
Amber Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  
Amber E Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)
Green Suitable first-line drugs for implementation in Primary Care  
Green Formulary South Staffs Formulary Choice

 


NetFormulary
   Visits = 233342
   Last updated: 12/09/2019 14:23:05